Editorial (Hot Topic: Exploring Molecular and Clinical Management of Patients in the Follow Up of the HPV Related Uterine Lesions) promotion: free to download

Pp: 1357-1357
Andrea Tinelli
DOI: 10.2174/1381612811319080001

Diagnostic Tests for the Detection of Human Papillomavirus-associated Cervical Lesions

Pp: 1358-1370
Miriam Reuschenbach and Magnus von Knebel Doeberitz
DOI: 10.2174/1381612811319080002

HPV Infections: Basis of Neoplastic Transformation and Related Molecular Tests

Pp: 1371-1378
Deborah French and Laura Lorenzon
DOI: 10.2174/1381612811319080003

HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies

Pp: 1379-1394
Susy M. Scholl, Maud Kamal, Leanne De Koning, Attila Kereszt, Ekaterina S. Jordanova, Sergiu Ungureanu, Els Berns and Xavier Sastre
DOI: 10.2174/1381612811319080004

Predictors and Clinical Implications of HPV Reservoire Districts for Genital Tract Disease

Pp: 1395-1400
George Koliopoulos, Olga Valari, Petros Karakitsos and Evangelos Paraskevaidis
DOI: 10.2174/1381612811319080005

HPV mRNA Testing in Triage of Women with ASC-US Cytology May Reduce the Time for CIN2+ Diagnosis Compared with Repeat Cytology

Pp: 1401-1405
Sveinung Wergeland Sorbye, Silje Fismen, Tore Jarl Gutteberg, Elin Synnøve Mortensen and Finn Egil Skjeldestad
DOI: 10.2174/1381612811319080006

Liquid-based Cytology With HPV Triage of Low-grade Cytological Abnormalities Versus Conventional Cytology in Cervical Cancer Screening

Pp: 1406-1411
Maria Froberg, Ingrid Norman, Bo Johansson, Anders Hjerpe, Elisabete Weiderpass and Sonia Andersson
DOI: 10.2174/1381612811319080007

Role of Cell Cycle Biomarkers in Human Papillomavirus Related Uterine Lesions

Pp: 1412-1424
Pablo Conesa-Zamora
DOI: 10.2174/1381612811319080008

Clinical Applicability of Microarray Technology in the Diagnosis, Prognostic Stratification, Treatment and Clinical Surveillance of Cervical Adenocarcinoma

Pp: 1425-1429
Julie Chepovetsky, Tamara Kalir and Elisabete Weiderpass
DOI: 10.2174/1381612811319080009

The Immunohistochemical Assessment of HPV Related Adenocarcinoma: Pathologic and Clinical Prognostic Significance

Pp: 1430-1438
Raluca Balan, Irina-Draga Caruntu and Cornelia Amalinei
DOI: 10.2174/1381612811319080010

The Problem of False-Positive Human Papillomavirus DNA Tests in Cervical Screening

Pp: 1439-1449
Matejka Rebolj, Igor Pribac, Maria Eiholm Frederiksen and Elsebeth Lynge
DOI: 10.2174/1381612811319080011

Detection of Residual/Recurrent Cervical Disease after Successful LEEP Conization: the Possible Role of mRNA-HPV Test

Pp: 1450-1457
Roberta Zappacosta, Manuel Maria Ianieri, Andrea Tinelli, Sarah Gustapane, Chiara D'Angelo, Daniela Maria Pia Gatta, Serena Capanna and Sandra Rosini
DOI: 10.2174/1381612811319080012

The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions

Pp: 1458-1465
Andrea Tinelli, Marcello Guido, Antonella Zizza, Marcello Pellegrino, Marilena Greco, Daniele Vergara, Ospan A. Mynbaev, Domenico Dell'Edera and Antonio Malvasi
DOI: 10.2174/1381612811319080013

Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe? open access plus

Pp: 1466-1487
Lucija Tomljenovic, Jean Pierre Spinosa and Christopher A. Shaw
DOI: 10.2174/1381612811319080014

Risk of Cervical Cancer After HPV Vaccination

Pp: 1488-1489
Maurie Markman
DOI: 10.2174/1381612811319080015

The Present and Future of Cervical Cancer Screening Programmes in Europe

Pp: 1490-1497
Paolo Giorgi Rossi and Guglielmo Ronco
DOI: 10.2174/1381612811319080016

Prevalence and Distribution of Human Papillomavirus Genotype in South Eastern Italy, in the Period 2006-2011: Implications for Intervention

Pp: 1498-1507
Marcello Guido, Andrea Tinelli, Antonella De Donno, Anna Rita Bruno, Luigi Tagliaferro, Alberto Fedele, Aniello Carbone, Paola Menegazzi, Valerio Aprile, Marilena Greco, Antonio Malvasi, Maria Antonietta Piccinni, Silvio Turano, Pierfrancesco Grima, Domenico Dell'Ederam and Antonella Zizza
DOI: 10.2174/1381612811319080017

Human Papillomavirus DNA and E6/E7 mRNA Testing as Triage in Liquid-Based Cytology Samples from Primary Screening open access plus

Pp: 1508-1515
Sonia Andersson, Miriam Mints, Elisabete Weiderpass and Bo Johansson
DOI: 10.2174/1381612811319080018

Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy

Pp: 1516-1527
Feng Yang, Zhi-Yi Chen and Yan Lin
DOI: 10.2174/1381612811319080019

Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry

Pp: 1528-1548
Yu'ning Song, Peng Zhan, Qingzhu Zhang and Xinyong Liu
DOI: 10.2174/1381612811319080020